Highlights of semi-synthetic developments from erythromycin A

Current Pharmaceutical Design

Volumn 6, Issue 2, 2000, Pages 181-223

  Wu, Yong Jin ^a,b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; IMINE; KETOLIDE; OXIME; PROKINETIC AGENT;

ANTIBACTERIAL ACTIVITY; BACTERIAL INFECTION; GASTROINTESTINAL DISEASE; ISOMERISM; PRIORITY JOURNAL; REVIEW; SACCHAROPOLYSPORA;

EID: 0034085604     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612003401316     Document Type: Review

References (108)

1. Macrolides: Chemistry, Pharmacology and Clinical Uses, (Eds.: Bryskier, A.J.; Butzler, J.P.; Neu, H.C; Tulkens, P.M.), Arnette Blackwell: Paris, 1993.
2. (b) New Macrolides, Azalides, and Streptogramins in Clinical Practice, (Eds.: Neu, H.C.; Young, L.S.; Zinner, S.H.; Acar, J.F.), Marcel Dekker: New York, 1995.
3. (c) Omura, S.; Tanaka, H. In Macrolide Antibiotics, Chemistry, Biology, and Practice, (ed.: Omura, S.), Academic Press: New York, 1984.
4. Malmborg, A.S. J. Antimicrob. Chemother., 1986, 18, 293-299.
5. (b) Hardy, D.J.; Hensey, D.M.; Beyer, J.M.; Vojtko, C.; MacDonald, E.J.; Fernandes, P.B. Antimicrob. Agents Chemother., 1988, 32, 1710-1719.
6. Welling, P.G.; Craig, A. J. Pharm. Sci. 1978, 67, 1057-1058.
7. Kurath, P.; Jones, P.H.; Egan, R.S.; Perun, T.J. Experientia, 1971, 27, 362.
8. Itoh, Z.; Nakaya, K.; Aria, H.; Wakabashi, K. Amer. J. Physiol., 1984, 247, G688-694.
9. For recent reviews on macrolides, see: (a) Kirst, H.A. Exp. Opin. Ther. Patents, 1998, 8, 111-120. (b) Chu, D.T.W. Exp. Opin. Invest. Drugs, 1995, 4, 65-94. (c) Bryskier, A. Exp. Opin. Invest. Drugs, 1997,6, 1697-1709.
10. For recent reviews on macrolides, see: (a) Kirst, H.A. Exp. Opin. Ther. Patents, 1998, 8, 111-120. (b) Chu, D.T.W. Exp. Opin. Invest. Drugs, 1995, 4, 65-94. (c) Bryskier, A. Exp. Opin. Invest. Drugs, 1997,6, 1697-1709.
11. For recent reviews on macrolides, see: (a) Kirst, H.A. Exp. Opin. Ther. Patents, 1998, 8, 111-120. (b) Chu, D.T.W. Exp. Opin. Invest. Drugs, 1995, 4, 65-94. (c) Bryskier, A. Exp. Opin. Invest. Drugs, 1997,6, 1697-1709.
12. Morimoto, S.; Takahashi, Y.; Adachi, T.; Nagate, T.; Watanabe, Y. J. Antibiotics, 1990, 43, 286-294.
13. Djokic, S; Kobrehel, G; Lazarevski, G. J. Antibiotics, 1987, 40, 1006-1015.
14. Bright, G.M.; Nagel, A.A.; Bornder, J.; Desai, K.A.; Dibrino, J.N.; Nowakowska, J.; Vincent, L.; Watrous, R.W.; Sciavolino, F.C.; English, A.R.; Retsema, J.R.; Anderson, M.A.; Brennan, L.A.; Borovoy, RJ.; Cimochowski, C.R.; Faiella, J.A.; Girard, A.E.; Girard, D.; Herbert, C.; Manousos, M.; Manson, R. J. Antibiotics, 1988, 4, 1029-1047.
15. Weisblum, B. Antimicrob. Agents Chernother., 1995, 39, 797-811.
16. (b) Leclercq, R; Courvalin, P. Antimicrob. Agents Chemother., 1991, 35, 1267-1272.
17. (c) Leclercq, R; Courvalin, P. Antimicrob. Agents Chemother., 1991, 35, 1273-1276.
18. (d) Sutcliffe, J.A.; Tait-Kamardat, A; Wondrack, L. Agents Chemother. 1996, 40, 1817-1824.
19. Agouridas, C.; Dennis, A; Auger, J.M.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J.F.; Dussarat, A.; Fromentin, C.; D'Ambrieres, S.G.; Lachaud, S; Laurin, P.; Martret, O.L.; Loyau, V.; Tessot, N. J. Med. Chem., 1998, 41, 4080-4100.
20. Graul, A; Castner, J. Drug Fut., 1998, 23, 591-597.
21. For a comprehensive review on motilides, see: Faghih, R.; Nellans, H.N.; Platter, J.J. Drug Fut., 1998, 23, 861-872.
22. Gasc, J.C.; D'Ambrieres, S.G.; Lutz, A.; Chantot, J.F. J. Antibiotics, 1991, 44, 313-330.
23. Wilkening, R.R.; Ratcliffe, R.W.; Doss, G.A.; Bartizal, K.F.; Graham, A.C.; Herbert, C.M. Bioorg. Med. Chem. Lett., 1993, 3, 1287-1292.
24. Waddell, S.T.; Santorelli, G.M.; Blizzard, T.A.; Graham, A.; Occi, J. Bioorg. Med. Chem. Lett., 1998, 8, 1321-1326.
25. Hirst, H.A.; Wind, J.A.; Leeds, J.P.; Willard, K.E.; Debono, M.; Bonjouklian, R.; Greene, J.M.; Sullivan, K.A.; Paschal, J.W.; Deeter, J.B.; Jones, N.D.; Ott, J.J.; Felty-Duckworth, A.M.; Counter, F.T. J. Med. Chem., 1990, 33, 3086-3094.
26. Pariza, R.J.; Lartey, P.A.; Maring, C.J.; Klein, L.L. US 5075289.
27. Leeds, J.P.; Kirst, H.A. Synth. Commun., 1988, 18, 777-782.
28. Djokic, S; Kobrehel, G.; Lazarevski, G.; Lopotar, N; Tamburasev, Z. J. Chem. Soc. Perkin. Trans, I, 1986, 1881-1890.
29. Yang, B.V.; Goldsmith, M; Rizzi, J.P. Tetrahedron Lett., 1994, 35, 3025-3028.
30. Wilkening, R.R.; Ratcliffe, R.W.; Doss, G.A.; Mosley, R.T.; Ball, R.G. Tetrahedron, 1998, 54, 16923-16944.
31. Djokic, S.; Kobrehel, G; Lopotar, N.; Nagl, A.; Mrvos, D. J. Chem. Res. Miniprint, 1988, 1239-1261.
32. Bayod-Jasanada, M; Carbajo, B.J.; Opez-Ortiz, F. J. Org. Chem., 1997, 62, 7479-7481.
33. Denis, A.; Agouridas, C. Bioorg. Med. Chem. Lett. 1998, 8, 2427-2432.
34. Faghih, R.; Nellans, H.N.; Lartey, P.A.; Petersen, A; Marsh, K.; Bennani, Y.L.; Platter, J.J. Bioorg. Med. Chem. Lett., 1998, 8, 805-810.
35. Faghih, R.; Edwards, C.M.; Freiberg, L.A.; Nellans, H.N. Synlett, 1998, 751-753.
36. Omura, S.; Tanaka, H. Macrolide Antibiotics, Chemistry, Biology, and Practice, chapter 1, (Ed.: Omura, S.), Academic Press: New York, 1984.
37. Kibwage, I.O.; Busson, R.; Janssen, G.; Hoogmartens, J.; Vanderhaeghe, H. J. Org. Chem., 1987, 52, 990-996.
38. Kirst, H.A.; Wind, J.A.; Paschal, J.W. J. Org. Chem., 1987, 52, 4359-4362.
39. Kirst, H.A.; Greenwood, B.; Gidda, J.S. Drugs Fut., 1992, 17, 16-20.
40. Burnell-Curty, C.; Faghih, R.; Pagano, T.; Henry, R.F.; Cartey, P.A. J. Org. Chem., 1996, 61, 5153-5154.
41. Waddell, S.T.; Blizzard, T.A. Tetrahedron Lett., 1992, 33, 7827-7830.
42. Baker, W.R.; Clark, J.D.; Stephens, R.L.; Kim, K.H. J. Org. Chem., 1988, 55, 2340-2345.
43. Griesgraber, G.; Or, Y.S.; Chu, D.T.W.; Nilius, A.M.; Johnson, P.M.; Flamm, R.K.; Henry, R.F. J. Antibiotics, 1996, 49, 465-477.
44. Agouridas, C.; Chantot, J. FR 2732684.
45. Agouridas, C.; Chantot, J.; Dennis, A.; D'Ambrieres, S.G.; Martret, O.L. EP 0680967A1.
46. Or, Y.S.; Griesgraber, G.W.; Chu, D.T.W. WO 9854197.
47. th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995, Abstr. No. F176.
48. th Interscience Conference on Antimacrobial Agents and Chemotherapy, Toronto, 1997, Abstr No. F263.
49. Or, Y.S.; Phan, L.T.; Chu, D.T.W.; Spina, K.P.; Hallas, R.; Elliott, R.L. WO 9717356.
50. th Interscience Conference on Antimacrobial Agents and Chemotherapy, Toronto, 1996, F264.
51. Wu, Y.J. WO 9851696.
52. A synthesis of the 2,3-anhydro counterpart of tricyclic ketolide 100 has been reported, see: Griesgraber, G.; Kramer, M.J.; Elliott, R.L.; Nilius, A.M.; Ewing, P.J.; Raney, P.M.; Bui, M.H.; Flamm, R.F.; Chu, D.T.W.; Platter, J.J.; Or, Y.S. J. Med. Chem., 1998, 41, 1660-1670.
53. Blizzard, T.A.; Waddell, S.T.; Santorelli, G.M.; Morgan, J.D. WO 9900124.
54. Or, Y.S.; Clark, R.F.; Chu, D.T.W.; Platter, J.J. US 5780605.
55. Or, Y.S.; Griesgraber, G.; Li, L.; Chu, D.T.W. WO 9921864.
56. LeMahieu, R.A.; Blount, J.F.; Kierstead, R.W. J. Antibiotics, 1975, 28, 705.
57. Huang, X.M.; Reamer, D.M.; Miller, L.H.; Gracey, H.E.; Montgomery, S.H.; Pagano, T.G.; Henry, R.F.; Liu, J.H. J. Antibiotics, 1996,49, 318-320.
58. Waddell, S.T.; Santorelli, G.M.; Blizzard, T.A.; Graham, A.; Occi, J. Bioorg. & Med. Chem. Lett., 1998, 8, 1321-1326.
59. Maier, R; Woitun, E.; Wetzel, B.; Reuter, W.; Goeth, H.; Lechner, U. DE 2515075.
60. Drugs Fut., 1989, 14, 112-115.
61. Blizzard, T.A.; Waddell, S.T.; Santorelli, G.M.; Morgan, J.D. WO 9900125.
62. Wu, Y.J. WO 9921865.
63. Jones, A.B.; Acton, J.J. III; Doss, G.A. Tetrahedron Lett.,1993, 34, 4913-4916.
64. Hauske, J.R.; Kostek, G. J. Org. Chem., 1982,47, 1595-1596.
65. th Interscience Conference on Antimacrobial Agents and Chemotherapy, 1997, Abstr. No F265.
66. Hauske, J.R.; Guadliana, M.; Kostek, G. J. Org. Chem., 1987, 52, 4622-4625.
67. Lartey, P.A.; Deninno, S.L.; Gaghih, R.; Hardy, D.J.; Clement, J.J.; Platter J.J.; Stephens, R.L. J. Med. Chem., 1991, 34, 3390-3395.
68. Elliott, R.L.; Pireh, D.; Griesgraber, D.; Nilius, A.M.; Ewing, P.J.; Bui, M.H.; Raney, P.M.; Flamn, R.F., Kim, K.; Henry, R.F.; Chu, D.T.W.; Platter, J.J.; Or, Y.S. J. Med. Chem., 1998, 47, 1651-1670.
69. Roden, B.A.; Chemburkar, S.; Freiberg, L.; Ku, Y.Y.; Pariza, R. Bioorg. & Med. Chem. Lett., 1995, 5, 1307-1310.
70. Morimoto, S.; Misawa, Y.; Adachi, T.; Nagate, T.; Watanabe, Y.; Omura, S. J. Antibiotics, 1990, 43, 286-294.
71. Ku, Y.Y.; Riley, D.; Grieme, T,.; Tien, J.; Zhang, X. J. Org. Chem., 1999, 64, 2107-2109.
72. Kobrehel, G.; Lazarevski, G.; Dokic, S.; Kolacny-Babic, L.; Kucisec-Tepes, N.; Cvrlje, M. J. Antibiotics, 1992, 45, 527-534.
73. Waddell, S.T.; Santorelli, G.M.; Blizzard, T.A.; Graham, A.; Occi, J. Bioorg. & Med. Chem. Lett. 1998, 8, 549-554.
74. Moromoto, S.; Adachi, T.; Misawa, Y.; Nagate, T.; Watanabe, Y.; Omura, S. J. Antibiotics, 1990, 43, 544-549.
75. Watanabe, Y.; Morimoto, S.; Adachi, T.; Kashimura, M.; Asaka, T. J. Antibiotics, 1993, 46, 647-660.
76. Watanabe, Y.; Kashimura, M.; Asaka, T.; Adachi, T.; Morimoto, S. Heterocycles, 1993, 36, 243-247.
77. Watanabe, Y.; Adachi, T.; Asaka, T.; Kashimura, M.; Matsunaga, T.; Moromoto, S. J. Antibiotcs, 1993, 46, 1163-1167.
78. Morimoto, S.; Adachi, T.; Matsunaga, T.; Asaka, T.; Watanabe, Y.; Sota, K.; Sekiuchi, K. US 4990602.
79. (b) Liu, J.H.; Foster, G.A.; Montgomery, S.H. WO 9719096.
80. th Interscience Conference on Antimacrobial Agents and Chemotherapy, 1998, Abstr. No F125.
81. th Interscience Conference on Antimacrobial Agents and Chemotherapy, 1998, Abstr. No F126.
82. Fujiwara, T.; Honda, E.; Hirano, T.; Sakakibara, H. JP 1983; 58-049396.
83. Lartey, P.A.; Nellans, H.N.; Faghih, R.; Petersen, A.; Edwards, C.M.; Freiberg, L.; Quigley, S.; Marsh, K.; Klein, L.L.; Platter, J.J. J. Med. Chem., 1995, 38, 1793-1798.
84. Elliott, R.L.; Pireh, D.; Nillus, A.M.; Johnson, P.M.; Flamm, R.K.; Chu, D.T.W.; Platter, J.J.; Or, Y.S. Bioorg. & Med. Chem. Lett., 1997, 7, 641-646.
85. Lartey, P.A.; Faghih, R.; Pagano, T.; Nellans, H.N.; Petersen, A.; Platter, J.J. J Antibiotics, 1995, 48, 730-732.
86. Barton, D.H.R.; McCombie, S.W. J. Chem. Soc. Perkin Trans. I,1975, 1574-1585.
87. Barlett, P.D.; Fuller, D.L.; Stanley, J.P. J. Amer. Chem. Soc., 1958, 80, 1398-1405.
88. Yang, B.V.; Massa, M.A. J. Org. Chem., 1996, 61, 5149-5152.
89. Freiberg, L. US 3725385.
90. Premchandran, R. US patent applied for November 22, 1996, case 6001.US.01.
91. Flynn, E.H.; Murphy, H.W.; McMahon, R.E. J. Amer. Chem. Soc., 1955, 77, 3104-3106.
92. Hengeveld, J.E.; Gupta, A.K.; Kemp, A.H.; Thomas, A.V. Tetrahedron lett., 1999,40, 2497-2500.
93. Ku, Y.Y.; Riley, D.; Patel, H.; Yang, C.X.; Liu, J.H. Bioorg. & Med. Chem. Lett. 1997, 7, 1203-1206.
94. Toscano, L. US 4673736.
95. (b) Toscano, L.; Fioriello, G.; Silingardi, S.; Inglesi, M. Tetrahedron, 1984, 40, 2177-2181.
96. Auricchio, S.; Fronza, G.; Meille, S.V.; Mele, A. J. Org. Chem., 1991, 56, 2250-2253.
97. Agouridas, C.; Bretin, F.; Chantot, J.F. FR2742757.
98. th Interscience Conference on Antimacrobial Agents and Chemotherapy, 1998, Abstr. No F127.
99. Pfitzner, K.E.; Moffatt, J.G. J. Amer. Chem. Soc., 1965, 87, 5661-5670.
100. Corey, E.J.; Kim, C.U. J. Amer. Chem. Soc., 1972, 94, 7586-7587.
101. (b) Corey, E.J.; Kim, C.U. J. Org. Chem., 1973, 38, 1233-1236.
102. (c) Corey, E.J.; Kim, C.U. Tetrahedron Lett., 1974, 287-290.
103. Freiberg, L.A.; Klein, L.L.; Yeung, C.M.; Edwards, C.M.; Bacino, D.J. US 5288709.
104. Dess, D.B.; Martin, J.C. J. Org. Chem., 1983, 48:, 155-4156.
105. (b) Dess, D.B.; Martin, J.C. J. Amer. Chem. Soc., 1991, 113, 7277-7278.
106. Martin, S.F.; Hida, T.; Kym, P.R.; Loft, M.; Hodgson, A. J. Amer. Chem. Soc., 1997, 119, 3193.
107. LeMahieu, R.A.; Carson, M.C.; Kierstead, R.W. J. Antibiotics, 1975, 28, 704.
108. Lemahieu, R.A.; Carson, M.; Kierstead, R.W. J. Med. Chem., 1974, 17, 953-956.